Biofrontera Inc. (BFRI) DCF Valuation

Biofrontera Inc. (BFRI) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Biofrontera Inc. (BFRI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

As an investor or analyst, this [Symbol] DCF Calculator is your go-to resource for accurate valuations. Equipped with real data from Biofrontera Inc., you can adjust forecasts and immediately observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 26.2 18.8 24.1 28.7 34.1 37.3 40.8 44.6 48.8 53.4
Revenue Growth, % 0 -28.01 27.86 18.98 18.82 9.41 9.41 9.41 9.41 9.41
EBITDA -8.1 -7.5 -36.8 .9 -18.5 -16.5 -18.1 -19.8 -21.7 -23.7
EBITDA, % -31.12 -39.75 -152.52 3.26 -54.16 -44.35 -44.35 -44.35 -44.35 -44.35
Depreciation .7 .6 .5 1.2 1.1 1.1 1.2 1.3 1.5 1.6
Depreciation, % 2.55 2.98 2.24 4.09 3.12 3 3 3 3 3
EBIT -8.8 -8.1 -37.3 -.2 -19.5 -17.5 -19.1 -20.9 -22.9 -25.1
EBIT, % -33.67 -42.73 -154.76 -0.83002 -57.28 -46.9 -46.9 -46.9 -46.9 -46.9
Total Cash 7.3 8.1 24.5 27.8 1.4 20.3 22.2 24.3 26.5 29.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.8 3.3 3.8 7.4 5.2
Account Receivables, % 18.28 17.45 15.7 25.83 15.15
Inventories 10.5 7.1 4.5 7.2 10.9 11.4 12.5 13.7 15.0 16.4
Inventories, % 40.03 37.62 18.5 25 32.02 30.63 30.63 30.63 30.63 30.63
Accounts Payable 7.2 1.5 .7 1.3 8.9 5.1 5.6 6.2 6.7 7.4
Accounts Payable, % 27.55 8.03 2.73 4.46 26.14 13.78 13.78 13.78 13.78 13.78
Capital Expenditure -.5 .0 .0 .0 .0 -.2 -.2 -.2 -.2 -.2
Capital Expenditure, % -2.05 0 -0.04564315 -0.13252 -0.01467524 -0.44955 -0.44955 -0.44955 -0.44955 -0.44955
Tax Rate, % -0.06959288 -0.06959288 -0.06959288 -0.06959288 -0.06959288 -0.06959288 -0.06959288 -0.06959288 -0.06959288 -0.06959288
EBITAT -8.8 -8.1 -37.4 -.3 -19.5 -17.5 -19.1 -20.9 -22.9 -25.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -16.8 -8.4 -35.5 -4.8 -12.3 -22.5 -19.3 -21.2 -23.1 -25.3
WACC, % 10.09 10.09 10.09 10.09 10.09 10.09 10.09 10.09 10.09 10.09
PV UFCF
SUM PV UFCF -83.7
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -26
Terminal Value -319
Present Terminal Value -198
Enterprise Value -281
Net Debt 4
Equity Value -285
Diluted Shares Outstanding, MM 2
Equity Value Per Share -184.53

What You Will Receive

  • Flexible Forecast Inputs: Adjust key assumptions (growth %, profit margins, discount rates) to explore various scenarios.
  • Comprehensive Data: Biofrontera Inc.’s financial information pre-loaded to facilitate your analysis.
  • Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Tailored and Professional: A refined Excel model that can be customized to meet your valuation requirements.
  • Designed for Analysts and Investors: Perfect for evaluating forecasts, confirming strategies, and enhancing efficiency.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics like revenue projections, profit margins, and R&D expenditures.
  • Instant DCF Valuation: Quickly calculates intrinsic value, net present value (NPV), and other financial metrics.
  • High-Precision Analytics: Leverages Biofrontera Inc.'s (BFRI) actual financial data for accurate valuation results.
  • Effortless Scenario Testing: Easily explore various assumptions and analyze their impacts on outcomes.
  • Efficiency Booster: Streamlines the valuation process, eliminating the need for complex model creation from the ground up.

How It Works

  • Download: Get the pre-prepared Excel file featuring Biofrontera Inc.'s (BFRI) financial metrics.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator for Biofrontera Inc. (BFRI)?

  • Designed for Industry Experts: A sophisticated tool utilized by healthcare analysts, financial advisors, and investors.
  • Comprehensive Data: Biofrontera Inc.’s historical and anticipated financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly test various projections and assumptions.
  • Concise Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.

Who Should Use This Product?

  • Investors: Accurately assess Biofrontera Inc.’s (BFRI) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Biofrontera Inc. (BFRI).
  • Consultants: Easily customize the template for valuation reports tailored to Biofrontera Inc. (BFRI) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques in the biotech sector.

What the Template Contains

  • Preloaded BFRI Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.